-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WMVvRnjPZZ/6L+DpuKhp70cRAIPALOyctIbZVJOSlQHE2infU4WjPJYi2s4zqoHa K+BYMrx4n2xk5HUL9W8Zcw== 0000893220-08-002051.txt : 20080714 0000893220-08-002051.hdr.sgml : 20080714 20080714143244 ACCESSION NUMBER: 0000893220-08-002051 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080714 DATE AS OF CHANGE: 20080714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDQUIST INC CENTRAL INDEX KEY: 0000884497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 222531298 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-13326 FILM NUMBER: 08950550 BUSINESS ADDRESS: STREET 1: 1000 BISHOPS GATE BLVD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054-4632 BUSINESS PHONE: 8568108000 MAIL ADDRESS: STREET 1: 1000 BISHOPS GATE BLVD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054-4632 8-A12B 1 w63043e8va12b.htm FORM 8-A e8va12b
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
MEDQUIST INC.
(Exact name of registrant as specified in its charter)
     
New Jersey   22-2531298
(State or other jurisdiction of   (I.R.S. Employer Identification No.)
incorporation or organization)    
     
1000 Bishops Gate Blvd, Suite 300, Mount Laurel, NJ   08054-4632
(Address of principal executive offices)   (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
     
    Name of each exchange on which
Title of each class to be so registered   each class is to be registered
Common Stock, no par value per share   The NASDAQ Stock Market LLC
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. þ
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o
Securities to be registered pursuant to Section 12(b) of the Act: None.
 
 

 

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1.   Description of Registrant’s Securities to be Registered
     For a description of the common stock, no par value per share (the “Common Stock”) of MedQuist Inc., a New Jersey corporation (the “Registrant”) to be registered hereunder, reference is made to the information set forth under the caption “Description of Capital Stock” in the Registrant’s Registration Statement on Form S-3 (file no. 333-75005), originally filed with the Securities and Exchange Commission on March 25, 1999, as amended, including any amendments or reports filed thereafter for the purpose of updating such description in which there is described the terms, rights and provisions applicable to the Registrant’s Common Stock. Such information shall be deemed to be incorporated by reference into this registration statement on Form 8-A.
Item 2.   Exhibits
     Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Exchange Act.

 

 

SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
         
  MedQuist Inc.
 		  
  By:   /s/ MARK R. SULLIVAN    
    Mark R. Sullivan   
    General Counsel, Chief Compliance
Officer & Secretary

Date: July 14, 2008		  
 

 

-----END PRIVACY-ENHANCED MESSAGE-----